Tektronix, a leading worldwide provider of measurement solutions, today introduced the TBS2000, a next generation basic oscilloscope featuring the longest record length and largest display in its class for faster signal evaluation and troubleshooting. This latest addition to the Tektronix portfolio puts expanded capabilities, including the ability to use a wide range of Tektronix probes, into the hands of budget-constrained design engineers and educators.
“Building on the success of the TDS2000 Series, the most widely used oscilloscope in the world, the new TBS2000 gives our customers a level of design insight previously not available in this class of instrument,” said Jeff Yost, director, Basic Oscilloscopes, Tektronix. “The new instrument also sets a new standard for usability with features like a large display for easy signal visualization and a comprehensive set of automatic waveform measurements that are coupled with graphical explanations to help engineers better understand their measurements.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7724651-tektronix-tbs2000-series-oscilloscope/
The Prostate Cancer Foundation (PCF) announces the launch of the “Step Up for Blue” Campaign for Prostate Cancer Awareness Month. The campaign honors the millions of men and their families touched by prostate cancer worldwide.
“Step Up for Blue” focuses on elevating critical issues to inspire, energize, and accelerate actions that lead to greater awareness, new therapies, and fewer deaths from prostate cancer. It will run through the duration of September.
To view the multimedia release go to:
http://www.multivu.com/players/English/7729253-pcf-step-up-for-blue-prostate-cancer/
Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research.
Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
Oklahoma State University (OSU) and the New York Philharmonic announced a residency partnership marking the opening of the new McKnight Center for the Performing Arts at OSU in October, 2019. The partnership is made possible in part by the visionary $25 million programming gift to OSU by alumni Billie and Ross McKnight. The McKnights’ gift established a program endowment to benefit all students, faculty and the Stillwater community by bringing top-tier residency programs and performances to OSU.
In addition to multiple New York Philharmonic performances at the McKnight Center conducted by future New York Philharmonic Music Director Jaap van Zweden, the residency partnership will include educational opportunities for OSU students with Philharmonic musicians and management, such as masterclasses, audition workshops and lectures. Every season the Philharmonic reaches millions of people through concerts at Lincoln Center in New York, worldwide tours, educational activities and outreach. The partnership with OSU adds to the Philharmonic’s growing list of educational partnerships throughout the U.S. and world, which includes the University Musical Society at the University of Michigan and New York Philharmonic Global Academy partnerships with Santa Barbara’s Music Academy of the West, The Shepherd School at Rice University and the Shanghai Symphony Orchestra.
To view the multimedia release go to:
http://www.multivu.com/players/English/7932451-osu-mcknight-new-york-philharmonic/
As part of its longstanding commitment to Africa, Johnson & Johnson today announced the launch of the Africa Innovation Challenge, an initiative to support Africa’s vibrant and growing innovation ecosystem and to help develop important and locally sustainable consumer health solutions. The challenge is the latest initiative in the company’s comprehensive approach to advancing health and innovation worldwide. The Johnson & Johnson Family of Companies’ presence in Africa dates back more than 80 years and includes business operations, public health programs and corporate citizenship.
“Through the Africa Innovation Challenge, we have the opportunity to support the continent’s top entrepreneurs through mentorship and other resources, and by working together with local talent, to bring forward new solutions to local health care challenges,” said Paul Stoffels, M.D., Executive Vice President and Chief Scientific Officer, Johnson & Johnson.
To view the multimedia release go to:
http://www.multivu.com/players/English/7967451-jnj-africa-innovation-challenge/
Online summer school enrollment is now open to K-12 students everywhere; offered by International Connections Academy (iNaCA), the U.S.-based accredited virtual private school serving students worldwide. Families are invited to attend an online information session to learn more about the benefits of online summer school.
iNaCA summer school students stay engaged academically while enjoying the freedom of summer. With more than 100 online courses - including NCAA eligible courses - flexible start dates, and enrichment opportunities, iNaCA's online summer school is an option for students interested in earning necessary credit, exploring fresh interests, and building new skills. Students also can use the innovative online summer program as a pathway to early graduation.
To view the multimedia release go to:
https://www.multivu.com/players/English/8007151-international-connections-academy-online-summer-school/
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients.
“The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
Tektronix, Inc., a leading worldwide provider of measurement solutions, has again broken through the innovation barrier with the introduction of the new 5 Series MSO mixed signal oscilloscope. To better meet modern electronics design challenges, the 5 Series MSO redefines the midrange oscilloscope with a host of innovations including the industry’s first FlexChannel™ technology that allows 4, 6 or 8 analog channels and up to 64 digital channels, integrated protocol analysis and signal generator, a new 12-bit signal acquisition system, a massive high-definition capacitive touch display, and a highly intuitive Direct Access user interface ¾ delivering unprecedented flexibility and unmatched visibility into complex embedded systems.
To view the multimedia release go to:
https://www.multivu.com/players/English/7990951-tektronix-5-series-mso-mixed-signal-oscilloscope/
Petmate, the worldwide leader of solutions and excellence in the pet industry providing trusted, quality products to enhance the lives of pets and their families, is launching a revolutionary new anxiety relief system for dogs. The Calmz Anxiety Relief System is now available at pet specialty and online retailers nationwide in time for the summer season of fireworks, thunderstorms and travel. For more information, visit calmz.com.
Nearly 75 million dogs owned by American families suffer from anxiety at some point in their lives, particularly as a result of thunderstorms, fireworks, encounters with strangers, travel and loud noises. About 24 million of them chronically suffer from these debilitating issues. Now Petmate introduces a new way to help relieve that anxiety.
To view the multimedia release go to:
https://www.multivu.com/players/English/8115451-petmate-calmz-anxiety-relief-system/
Hennessy, the world’s best-selling Cognac, is proud to announce urban artist JonOne as the designer of the 2017 Hennessy Very Special Limited Edition bottle. The custom-designed bottle, launching across the U.S. in July 2017, will be sold in almost 50 countries worldwide. The Limited Edition release by JonOne, which features a colorful, vibrant design, is the seventh in an ongoing series of collaborations between Hennessy V.S and several internationally renowned artists.
Hennessy sensed a kindred spirit in JonOne. Constantly on the move between his home in Paris, his native Harlem and cutting-edge art scenes all over the world, the street artist-turned-art-world phenomenon has always remained true to himself, pushing boundaries and defying definition. For JonOne, art is a vector for pure emotion. What drives him is being “in the flow” and “sharing dreams.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8120351-hennessy-jonone-very-special-limited-edition-bottle/
Melbourne-born Quay Australia, a leading eyewear company, announces a high-profile sunglass collaboration with pop culture phenomenon and entrepreneur, Kylie Jenner.
The QUAYXKYLIE capsule collection—comprised of 4 styles and 11 skus—will be available beginning July 11th at www.QuayAustralia.com and retailers worldwide for $75-$80 USD each.
“We’ve found the perfect collaborator in Kylie. Her social influence is unparalleled and she is known for her dynamic style and edge that her followers want to emulate,” says Quay Australia founder, Linda Hammond.
To view the multimedia release go to:
https://www.multivu.com/players/English/8127151-quay-australia-kylie-jenner-sunglass-collection-quayxkylie/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
